KY MSSP Enhanced
Erin Patrick
ACO Primary Contact
202-803-7979
Location
Location

AmpliPHY of Kentucky ACO LLC
4550 Montgomery Ave, Ste 950N
Bethesda, MD 20814
 

ACO Participants ACO Participant in Joint Venture
Advanced Internal Medicine PLLC N
Dr. Butler & Associates, PLLC N
Four Rivers Internal Medicine PLLC N
GOLDENBERG & ASSOCIATES N
James Kyle Turnbo MD PSC N
JAMES N EICKHOLZ MD PSC N
Jeffrey L. Riney M.D. & Associates PLLC N
JEREMY BRADLEY N
Kyle D. Parish, MD, PSC N
Total Life Care, PLLC N

Member First Name Member Last Name Member's Voting Power (Expressed as a percentage or number) Membership Type Practice Legal Business Name
Kyle Turnbo 1 ACO Participant Representative James Kyle Turnbo MD PSC
Danny Butler 1 ACO Participant Representative Dr. Butler & Associates, PLLC
James Eickholz 1 ACO Participant Representative James Eickholz, M.D., P.S.C
Erin Patrick 1 Other Aledade
Ryan Frazine 1 ACO Participant Representative Advanced Internal Medicine PLLC
Jeremy Bradley 1 ACO Participant Representative Jeremy L. Bradley MD
Jason Lorch 1 ACO Participant Representative Four Rivers Internal Medicine PLLC
Kyle Parish 1 ACO Participant Representative Kyle. D. Parish, MD, PSC
Jennifer Nelson 1 ACO Participant Representative Total Life Care, PLLC
Jeffrey Riney 1 ACO Participant Representative Jeffrey L. Riney MD & Associates PLLC
Van Meeks 1 ACO Participant Representative Total Life Care, PLLC
Shabbir Shaikh 1 ACO Participant Representative Goldenberg & Associates
Pam Storm 1 Medicare Beneficary Represtative N/A

  • Executive Director: Ms. Erin Patrick 
  • Medical Director: Dr. Ryan Frazine
  • Compliance Officer: Ms. Sarah Chasson
  • Quality Assurance/Improvement Officer: Dr. Emily Maxson
  • Compliance Committee: Dr. Danny Butler
  • Networks of individual practices of ACO professionals
  • Second Agreement Period 

    • Performance Year 2020, $ 5,023,158

    • Performance Year 2019, $1,665,855

  • First Agreement Period

    • Performance Year 2019, $1,665,855

    • Performance Year 2018, $0

    • Performance Year 2017, $0

    • Performance Year 2016, $1,110,552

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019

Second Agreement Period

  • Performance Year 2020
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 40%
    • Proportion of distribution to ACO participants: 50%
  • Performance Year 2019
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 40%
    • Proportion of distribution to ACO participants: 50%

First Agreement Period 

  • Performance Year 2019
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%
  • Performance Year 2016
    • Proportion invested in infrastructure: 10%
    • Proportion invested in redesigned care processes/resources: 30%
    • Proportion of distribution to ACO participants: 60%

Note: Our ACO participated in multiple performance years during Calendar Year 2019. Distribution of shared savings reported for Performance Year 2019 therefore represents the distribution of the net shared savings across all performance years in 2019 and is shown under all agreement periods in which the ACO operated during Calendar Year 2019

 

2020 Quality Performance Results:
ACO#
Measure Name
Rate
ACO Mean
ACO-8
Risk Standardized, All Condition Readmission
14.61
15.07
ACO-38
Risk-Standardized Acute Admission Rates for Patients with Multiple Chronic Conditions
40.57
49.50
ACO-43
Ambulatory Sensitive Condition Acute Composite (AHRQ* Prevention Quality Indicator (PQI #91))
0.82
0.95
ACO-13
Falls: Screening for Future Fall Risk
95.96
84.97
ACO-14
Preventive Care and Screening: Influenza Immunization
84.46
76.03
ACO-17
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention
95.45
81.67
ACO-18
Preventive Care and Screening: Screening for Depression and Follow-up Plan
95.09
71.46
ACO-19
Colorectal Cancer Screening
87.00
72.59
ACO-20
Breast Cancer Screening
89.13
74.05
ACO-42
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease
78.59
83.37
ACO-40
Depression Remission at Twelve Months
20.27
13.99
ACO-27
Diabetes Mellitus: Hemoglobin A1c Poor Control
10.97
14.70
ACO-28
Hypertension (HTN): Controlling High Blood Pressure
84.76
72.87

 

For Previous Years’ Financial and Quality Performance Results, Please Visit data.cms.gov.

 

Payment Rule Waivers

Skilled Nursing Facility (SNF) 3-Day Rule Waiver:

  • Our ACO uses the SNF 3-Day Rule Waiver, pursuant to 42 CFR § 425.612.

Waiver for Payment for Telehealth Services:

  • Our ACO clinicians provide telehealth services using the flexibilities under 42 CFR § 425.612(f) and 42 CFR § 425.613.
Fraud and Abuse Waivers